Forbes November 8, 2023
Bruce Japsen

Weight loss prescriptions Wegovy, Rybelsus and Saxenda – along with Ozempic – are driving health costs for employers up by more than $300 per insured worker this year, new data from benefits consultancy Aon says.

These GLP-1 drug costs are expected to boost healthcare spending through 2025, increasing from $324 per insured member this year up to $500 per insured health plan member in two years, new data from the benefits consultancy Aon says. By comparison, annual spending on such prescriptions in 2021 was $96 per member, Aon data shows.

Aon’s analysis comes from its Aon Rx claims data from nearly 500 employers and their 4.4 million health plan members. Aon said weight loss prescriptions Wegovy, Rybelsus and Saxenda have...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer, Insurance, Patient / Consumer
A new COVID variant is on the rise. Here's what to know about LP.8.1
Enrollment Growth in the ACA Marketplaces
FHC #170: AI could save 500,000 lives, $1.5 trillion a year, says Dr. Pearl
Healthcare: It’s Just Business
Record high: 91 million Americans can't afford health care

Share This Article